Canary Capital filed an amended S-1 registration statement with the SEC on September 24, 2026 for a Staked INJ ETF with the ticker INJC. The fund will hold INJ tokens directly for spot price exposure and plans to stake approximately 90 percent of its holdings to generate additional rewards. BitGo will serve as custodian and listing is planned on Cboe BZX. At least three INJ-related ETF applications are pending with the SEC, including proposals from Canary Capital, 21Shares, and REX-Osprey. Injective CEO Eric Chen suggested on October 5, 2026 that a launch before 2027 could be feasible, challenging more conservative timelines.
Source: Read the original article

